Adenosine a2a receptor antagonists

Details Adenosine a2a receptor antagonists Adenosine a2a receptor antagonists

C - Chemistry, Metallurgy

07

D

C07D 487/04 (2006.01) A61K 31/522 (2006.01) A61P 25/16 (2006.01)

Patent

CA 2655987

Compounds having the structural formula (I) or a pharmaceutically acceptable salt thereof, wherein: X1 and X2 are 1-3 substituents independently selected from the group consisting of H, alkyl, halo, -CF3, -OCF3, alkoxy, -OH and -CN; n is 0, 1 or 2; and R and R1 are H or alkyl; also disclosed is the use of the compounds in the treatment of CNS diseases such as Parkinson's disease, alone or in combination with other agents for treating CNS diseases, pharmaceutical compositions comprising them and kits comprising the components of the combinations.

L'invention concerne des composés possédant la formule structurelle (I) ou son sel pharmacocompatible. Dans cette formule, X1 et X2 représentent des substituants 1-3 choisis indépendamment parmi le groupe comprenant H, un alkyle, halo, -CF3, -OCF3, un alkoxy, -OH et -CN; n est égal à 0, 1 ou 2; et R et R1 représentent H ou un alkyle. Cette invention a aussi pour objet l'utilisation des composés pour traiter des maladies du SNC, telles que la maladie de Parkinson, seuls ou mélangés à d'autres agents destinés à traiter des troubles du SNC, ainsi que des compositions pharmaceutiques les contenant et des kits comprenant les composants de ces mélanges.

Affiliated with

Also associated with

Rating

Adenosine a2a receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adenosine a2a receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenosine a2a receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2011113